Announcements & Circulars-Alphamab Oncology

English 中文简体中文繁体

English 中文简体中文繁体

Investors

Information Disclosure

Listing Documents

Financial Reports

Announcements & Circulars

Company Presentation

Corporate Governance

Stock Information

Corporate Communications

Email Subscription

Announcements & Circulars

The announcement begins in December 2019

Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2025 2025-11-06
Next Day Disclosure Return 2025-10-28
VOLUNTARY ANNOUNCEMENT – JSKN003 WAS GRANTED FTD BY THE U.S. FDA FOR THE TREATMENT OF PROC 2025-10-27
GRANT OF AWARD SHARES UNDER THE RESTR 2025-10-24
VOLUNTARY ANNOUNCEMENT – RESEARCH UPDATES OF JSKN003 FOR PRESENTATION AT ESMO CONGRESS 2025 2025-10-20
VOLUNTARY ANNOUNCEMENT – JSKN003 WAS GRANTED ANOTHER BREAKTHROUGH THERAPY DESIGNATION BY THE CDE 2025-10-20
VOLUNTARY ANNOUNCEMENT - RESEARCH UPDATES ON A PHASE III CLINICAL TRIAL OF KN026 PRESENTED AT ESMO CONGRESS 2025 LBA ORAL PRESENTATION SESSION 2025-10-17
Next Day Disclosure Return 2025-10-16
Next Day Disclosure Return 2025-10-14
SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO THE 2024 ANNUAL REPORT 2025-10-13